Citation: | Nuerguli·AIYITI, Dilibaier·ANWAIER, TANG Xuelian. Application value of ultrasound microvascular imaging in late pregnancy with pregnancy-induced hypertension[J]. Journal of Clinical Medicine in Practice, 2024, 28(20): 82-85, 91. DOI: 10.7619/jcmp.20242303 |
To investigate the application value of ultrasound microvascular imaging in monitoring placental blood perfusion and predicting pregnancy outcomes in late pregnancy with pregnancy-induced hypertension.
A retrospective analysis was conducted in 150 pregnant women with pregnancy-induced hypertension in late gestation(study group), and another 150 pregnant women with normal pregnancy outcomes in late gestation during the same period were selected as control group. Both groups underwent ultrasound microvascular imaging, and the peak systolic velocity to end diastolic velocity ratio(S/D), pulsatility index (PI), resistance index (RI), vascularization index (VI) of the placenta, and the Apgar score at 1 minute after birth were recorded. Based on the severity of the disease, the study group was further divided into mild group (63 cases), moderate group (49 cases), and severe group(38 cases). According to the occurrence of adverse pregnancy outcomes, the study group was further divided into poor prognosis group (47 cases) and good prognosis group (103 cases). Receiver operating characteristic (ROC) curves were plotted to analyze the predictive value of each indicator for adverse pregnancy outcomes in pregnant women with pregnancy-induced hypertension.
The S/D, PI, and RI were higher in the study group than in the control group, while the VI and Apgar scores were lower in the study group (P < 0.05). There were statistically significant differences in S/D, PI, RI, VI, and Apgar scores among pregnant women with different severities of pregnancy-induced hypertension (P < 0.05). The S/D, PI, and RI were higher in the poor prognosis group than in the good prognosis group, while the VI and Apgar scores were lower in the poor prognosis group (P < 0.05). ROC curve analysis showed that the areas under the curve (AUCs) for predicting adverse pregnancy outcomes by S/D, PI, RI, VI, and Apgar scores were 0.741, 0.700, 0.738, 0.774, and 0.680, respectively (P < 0.05).
Placental blood perfusion decreases significantly in late pregnancy with pregnancy-induced hypertension, and ultrasound microvascular imaging parameters, especially VI, can effectively assist in clinically assessing pregnancy outcomes.
[1] |
杨孜. 妊娠期高血压疾病诊治新观点: 谈诊治概念与理念之碰撞[J]. 实用妇产科杂志, 2021, 37(3): 168-171.
|
[2] |
陈祯, 高霞, 赵杨, 等. 胎盘血流灌注监测妊娠期高血压孕妇药物治疗效果研究[J]. 实用医学杂志, 2021, 37(17): 2219-2223. doi: 10.3969/j.issn.1006-5725.2021.17.010
|
[3] |
MORLEY L C, DEBANT M, WALKER J J, et al. Placental blood flow sensing and regulation in fetal growth restriction[J]. Placenta, 2021, 113: 23-28. doi: 10.1016/j.placenta.2021.01.007
|
[4] |
谭杰, 姚玮, 孙翔. 三维能量多普勒超声在妊娠期子痫患者胎盘功能评估中的应用[J]. 中国优生与遗传杂志, 2020, 28(11): 1353-1355.
|
[5] |
姜瑜, 刘艳, 杨丹, 等. 超微血流成像技术在评估妊娠期高血压疾病胎盘灌注中的应用价值分析[J]. 解放军医学院学报, 2022, 43(6): 634-638, 699. doi: 10.3969/j.issn.2095-5227.2022.06.004
|
[6] |
谢幸, 孔北华, 段涛. 妇产科学[M]. 9版. 北京: 人民卫生出版社, 2018: 53-57, 83-90.
|
[7] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4): 227-238.
|
[8] |
钟咏华, 董敏, 朱丹. 超声检测妊娠期高血压疾病患者胚胎心率对妊娠结局的预测价值[J]. 中国妇幼保健, 2021, 36(17): 4132-4134.
|
[9] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要[J]. 心脑血管病防治, 2023, 23(7): 1-19, 24. doi: 10.3969/j.issn.1009-816x.2023.07.001
|
[10] |
CHEN S, LI N, MEI Z G, et al. Micronutrient supplementation during pregnancy and the risk of pregnancy-induced hypertension: a randomized clinical trial[J]. Clin Nutr, 2019, 38(1): 146-151. doi: 10.1016/j.clnu.2018.01.029
|
[11] |
李晶, 田海涛, 王鸿燕, 等. 《2018欧洲心脏病学会妊娠期心血管疾病管理指南》妊娠期高血压疾病解读[J]. 转化医学杂志, 2020, 9(1): 53-56.
|
[12] |
吴婷, 刘燕娜, 章春泉, 等. 三维超声监测胎儿宫内缺氧颅脑和胎盘血流灌注的价值研究[J]. 中国超声医学杂志, 2021, 37(6): 663-666. doi: 10.3969/j.issn.1002-0101.2021.06.020
|
[13] |
刘丽. 胎儿生长受限孕妇胎盘血流状态指标的变化及临床意义[J]. 山东医药, 2021, 61(13): 81-83.
|
[14] |
胡振芳, 张金辉. 阴道三维能量多普勒超声血管参数在子宫瘢痕妊娠治疗中的临床意义研究[J]. 中国性科学, 2020, 29(8): 36-38.
|
[15] |
CAO Q H, MA C, ZHU J B. Ultrasound Doppler fetal heart rate detection algorithm analyzes the correlation between twin selective fetal growth restriction and cord blood SFass fasL level[J]. Pak J Med Sci, 2021, 37(6): 1672-1676.
|
[16] |
史微, 李建丽, 史莉玲. 微血流灌注成像与脐动脉频谱多普勒预测妊娠期高血压疾病不良妊娠结局的对比研究[J]. 临床超声医学杂志, 2022, 24(8): 621-624.
|
[17] |
张婷婷, 张宝, 金镇. 母体妊娠期高血压疾病合并新生儿低Apgar评分预测模型的建立[J]. 中国医药, 2022, 17(3): 437-442.
|
[18] |
CHEN X L, WEI X, ZHAO S, et al. Characterization of placental microvascular architecture by MV-flow imaging in normal and fetal growth-restricted pregnancies[J]. J Ultrasound Med, 2021, 40(8): 1533-1542.
|
[19] |
魏彦萍, 李树深, 吴变霞, 等. 超声微血管成像定量评估妊娠期高血压疾病患者胎盘血流灌注的价值及与胎儿不良妊娠结局的关系[J]. 中国妇幼保健, 2023, 38(15): 2921-2924.
|
[20] |
牛梓涵, 张培培, 武玺宁, 等. 超声微血管成像评价胎盘灌注与胎儿生长发育关系的初步研究[J]. 中华超声影像学杂志, 2021, 30(8): 691-696.
|